Foresite Capital Management II’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-877,134
Closed -$3.41M 16
2017
Q1
$3.41M Sell
877,134
-17,561
-2% -$68.3K 1.46% 7
2016
Q4
$3.34M Sell
894,695
-5,460
-0.6% -$20.4K 1.68% 6
2016
Q3
$3.74M Hold
900,155
1.78% 7
2016
Q2
$4.18M Buy
900,155
+12,354
+1% +$57.3K 2.86% 9
2016
Q1
$2.93M Buy
887,801
+13,800
+2% +$45.5K 1.43% 14
2015
Q4
$2.98M Buy
874,001
+165,669
+23% +$565K 1% 16
2015
Q3
$2.58M Hold
708,332
0.78% 17
2015
Q2
$3.52M Hold
708,332
1.24% 17
2015
Q1
$5.69M Buy
+708,332
New +$5.69M 3.37% 7